Rachel Alt-Simmons
Head of Business Architecture & Design, AXA XL
Rachel Alt-Simmons, MBB, PMI-ACP, PMP, CSM, is Head of Business Architecture & Design at AXA XL and an adjunct faculty member at Boston University. Formerly she was a principal consultant within the Financial Services Practice at SAS Institute. She is a performance-excellence business intelligence (BI) and analytics practitioner with deep experience in the insurance and financial services industries.
By This Author
Agile by Design: An Implementation Guide to Analytic Lifecycle Management
By Rachel Alt-Simmons
Achieve greater success by increasing the agility of analytics lifecycle management
Agile by Design offers the insight you need to improve analytic lifecycle management while integrating the right analytics projects into different frameworks within your business. You will explore, in-depth, what analytics projects are and why they are set apart from traditional development initiatives. Beyond merely defining analytics projects, Agile by Design equips you with the information you need to apply agile methodologies in a way that tailors your approach to individual initiatives—and the needs of your projects and team.
Featured Authors
-
Terisa Roberts is a director and Global Solution lead for Risk Modeling and Decisioning at SAS. She has extensive experience in quantitative risk management, regulatory compliance, and model governance and validation. She has worked in financial services, telecommunications, government, energy, and retail sectors.
-
Ron Klimberg, PhD, is a professor at the Haub School of Business at Saint Joseph's University in Philadelphia, PA.
-
Robert N. Rodriguez retired from SAS in 2018 after serving as a senior director in research and development. Bob received a PhD in statistics from the University of North Carolina at Chapel Hill and was a research statistician at General Motors Research Laboratories before joining SAS.
-
Todd Case has been working in the pharmaceutical industry as a statistical programmer for over 20 years. He completed his MS in Epidemiology from Columbia University and has worked at Forest Laboratories (now Allergan), Genentech, Bristol-Myers Squibb, and Biogen. He currently works at Vertex Pharmaceuticals.